Clinical Trial Detail

NCT ID NCT03844048
Title An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
Recruitment Enrolling by invitation
Gender both
Phase Phase III
Variant Requirements No
Sponsors AbbVie
Indications

cancer

Therapies

Venetoclax

Age Groups: child adult senior

No variant requirements are available.